Corrigendum

Errata

This article corrects:

  1. Flebogamma® 5% DIF development: rationale for a new option in intravenous immunoglobulin therapy Volume 157, Issue s1, 17–21, Article first published online: 10 June 2009

No abstract is available for this article.

Ancillary